Trump's Tobacco Stock Holdings and Industry Donations Surge as FDA Eases Vaping and Nicotine Pouch Standards
核心洞察
President Trump accumulated up to $1.64 million in Philip Morris (搜索) stock while tobacco interests donated over $20 million to MAGA Inc. since late 2023.
The FDA in May 2025 issued guidance allowing flavored vapes and nicotine pouches to be marketed while awaiting agency approval, drawing sharp criticism from public health leaders.
Former FDA tobacco center director Mitch Zeller called the guidance "blatantly illegal," while the American Lung Association said the FDA "ignored scientific evidence."
President Donald Trump, who once declared he had "saved" flavored vapes, grew his stock holdings this year to as much as $1.64 million in tobacco giant Philip Morris (搜索), while also holding positions in Altria (搜索) and a third leading tobacco company. In 2025, tobacco interests donated $6 million to MAGA Inc., the super PAC supporting the president, and his inauguration. On April 30, one week before FDA guidance that provided a critical boost to the industry, Reynolds American (搜索) dropped an additional $5 million into the super PAC's coffers.
The stock trades and political contributions occurred as the Trump administration pursued a broadly pro-tobacco agenda: the FDA piloted a fast-track program to approve nicotine pouches, unveiled a program to allow vapes on the market more rapidly, and issued guidance waving through flavored electronic cigarettes. The administration also cut public health employees focusing on anti-tobacco policy and broadened enforcement against illicit e-cigarettes — competitors to the large industry players with financial ties to Trump.
"It amounts to the most pro-tobacco, pro-nicotine presidency in some time — a remarkable policy given the tens of millions of deaths cigarettes caused during the 20th century," the investigation found. Anti-smoking groups estimate that a half-million Americans die annually from cigarettes.
Financial Disclosures and Industry Contributions
Since late 2023, MAGA Inc. has received over $20 million in funding from the tobacco industry, federal campaign records show. Trump's inauguration garnered nearly $4 million more. His ballroom project has disclosed donations of an unknown amount from Altria (搜索) and Reynolds American (搜索).
In March, Trump made eight separate purchases of Philip Morris (搜索) or Altria (搜索) stock, worth as much as $275,000, according to a disclosure form bearing his signature. However, the financial disclosures show only ranges of investment amounts, and an apparent discrepancy clouds the full picture: in January, the president sold $500,000 to $1,000,000 in Altria stock, yet previous disclosures did not show Trump held that much equity in Altria. The White House declined to comment on the matter.
The financial stakes are substantial. Investment analysts at Goldman Sachs said in March 2025 that Philip Morris (搜索) expects Zyn pouches to make eight times the gross profits of its cigarettes.
FDA Guidance and Public Health Backlash
In May 2025, the FDA released consequential guidance allowing manufacturers to market their vapes and nicotine pouches while awaiting agency approval, and also approved several vaping products. The month prior, the Vapor Technology Association, which donated $1.25 million to Trump's inauguration, told its vape-manufacturer members it had met with the White House to discuss its concerns.
The guidance drew swift condemnation. "After years of recognizing the dangers flavored e-cigarettes pose to youth, it is deeply troubling to see FDA ignore the scientific evidence and reverse course," said American Lung Association CEO Harold Wimmer.
Mitch Zeller, a former head of the FDA's tobacco center, went further: "I think it's blatantly illegal, both on its merits and also procedurally, because it was issued as a final guidance without even giving the public an opportunity to comment on it."
A group of Democratic senators called the decision "a free pass to addictive and harmful vapes" in letters to Reynolds American (搜索) and Altria (搜索), concluding it would lead to "a lucrative payday after years of unsuccessful legislative and regulatory efforts to weaken federal tobacco oversight."
White House and Industry Response
The White House did not comment on the president's investments or industry donations. Spokesperson Kush Desai stated, "The only guiding factor behind the Trump administration's health policymaking is Gold Standard Science. FDA's regulatory treatment of nicotine pouches and vapes is rooted in recent evidence that has found that these products can help adults quit smoking."
Philip Morris (搜索) disputed any connection between its political engagement and regulatory outcomes. Spokesperson Samuel Dashiell said company representatives "regularly attend events and forums where we share our commitment to improving public health in the United States, starting with providing better options to America's 45 million legal-age nicotine consumers." He added, "We do not comment on individual engagements or on the personal financial matters or disclosures of public officials."
Other tobacco companies — Juul (搜索), Reynolds American (搜索), and Altria (搜索) — did not respond to requests for comment.
Analyst Reactions and Regulatory Context
Trump's tobacco policies have garnered favorable assessments from investors. Goldman Sachs bankers described the May FDA guidance as "very positive" for Philip Morris (搜索) and "a significant step in the FDA's positioning toward enforcement and acceptance of nic pouch (as well as e-vapor) innovation generally." Barclays analysts said the guidance was good news for Juul (搜索), which contributed $1 million to MAGA Inc. in November.
FDA resistance to speeding up approvals reportedly contributed to the ouster of agency commissioner Marty Makary. According to The New York Times and The Wall Street Journal, the White House repeatedly intervened in the approval process.
"I served during the entire first Trump administration as center director, and there was never any pressure from any political appointee at FDA, at HHS, or the White House when it came to application review," Zeller said, contrasting the current environment.
Public Health Infrastructure Impact
The Trump administration's government layoffs have decimated public health tobacco control offices. The CDC's office of smoking has seen its work sharply curtailed, and its flagship "Tips From Former Smokers" campaign has been off the air for months, according to Brian King, who was pushed out of the FDA's tobacco office and now works at the Campaign for Tobacco-Free Kids.
"It's not difficult to see that less dollars invested in prevention and control is going to lead to more tobacco product use and tobacco-related disease," King said, calling the scale of industry money "unprecedented and problematic."
King highlighted the irony given the administration's "Make America Healthy Again" focus on chronic disease: "Attempting to combat chronic disease without tobacco control is like attempting a triathlon without a bicycle: You are destined for failure before leaving the starting line."
The administration has also withdrawn a Biden-era proposal to ban menthol cigarettes and eased the path for nicotine pouches such as Zyn. Investment analysts viewed government crackdowns on illicit e-cigarettes positively, with Barclays writing in January that "company commentary on enforcement has also been upbeat, suggesting that the tide could begin to turn in favour of the legal players in the market."